Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-11-033123
Filing Date
2011-05-31
Accepted
2011-05-31 11:27:18
Documents
4
Period of Report
2011-05-31

Document Format Files

Seq Description Document Type Size
1 6-K v224561_6k.htm 6-K 1122574
2 GRAPHIC footerrule.jpg GRAPHIC 8248
3 GRAPHIC logo.jpg GRAPHIC 9018
4 GRAPHIC logo1.jpg GRAPHIC 6061
  Complete submission text file 0001144204-11-033123.txt   1156138
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 11880215
SIC: 2834 Pharmaceutical Preparations